8-(4-sulfophenyl)theophylline has been researched along with sphingosine 1-phosphate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Honbo, N; Karliner, JS; Li, L; Vessey, DA | 1 |
1 other study(ies) available for 8-(4-sulfophenyl)theophylline and sphingosine 1-phosphate
Article | Year |
---|---|
Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning.
Topics: Adenosine; Animals; Animals, Newborn; Cells, Cultured; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lysophospholipids; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Perfusion; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Receptors, Purinergic P1; Recovery of Function; Signal Transduction; Sphingosine; Theophylline; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2009 |